Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|October 24, 1981
HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccinesF A Ennis, A H Rook, Y H Qi, et al.
The Journal of Investigative Dermatology|February 14, 2002
Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphomaMohamed H Zaki, Maria Wysocka, Suzanne E Everetts, et al.
Archives of Dermatology|March 23, 2005
Biological effects of bexarotene in cutaneous T-cell lymphomaJeanne B Budgin, Stephen K Richardson, Sarah B Newton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10Y Geng, R B Shane, K Berencsi, et al.
Journal of Biological Response Modifiers|October 1, 1984
Use of interleukin-2 in patients with acquired immunodeficiency syndromeH C Lane, J P Siegel, A H Rook, et al.
Annals of Internal Medicine|May 15, 1990
L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosisB Freundlich, V P Werth, A H Rook, et al.
Reviews of Infectious Diseases|March 1, 1984
HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infectionsG V Quinnan, W H Burns, N Kirmani, et al.
Annals of Internal Medicine|January 1, 1984
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerationsA S Fauci, A M Macher, D L Longo, et al.
The Yale Journal of Biology and Medicine|November 1, 1989
Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary reportA H Rook, P W Heald, G T Nahass, et al.
Acta Dermato-Venereologica|March 23, 2016
Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the SkinLeigh A Nattkemper, Maria-Estela Martinez-Escala, Ari B Gelman, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|October 24, 1981
HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccinesF A Ennis, A H Rook, Y H Qi, et al.
The Journal of Investigative Dermatology|February 14, 2002
Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphomaMohamed H Zaki, Maria Wysocka, Suzanne E Everetts, et al.
Archives of Dermatology|March 23, 2005
Biological effects of bexarotene in cutaneous T-cell lymphomaJeanne B Budgin, Stephen K Richardson, Sarah B Newton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10Y Geng, R B Shane, K Berencsi, et al.
Journal of Biological Response Modifiers|October 1, 1984
Use of interleukin-2 in patients with acquired immunodeficiency syndromeH C Lane, J P Siegel, A H Rook, et al.
Annals of Internal Medicine|May 15, 1990
L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosisB Freundlich, V P Werth, A H Rook, et al.
Reviews of Infectious Diseases|March 1, 1984
HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infectionsG V Quinnan, W H Burns, N Kirmani, et al.
Annals of Internal Medicine|January 1, 1984
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerationsA S Fauci, A M Macher, D L Longo, et al.
The Yale Journal of Biology and Medicine|November 1, 1989
Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary reportA H Rook, P W Heald, G T Nahass, et al.
Acta Dermato-Venereologica|March 23, 2016
Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the SkinLeigh A Nattkemper, Maria-Estela Martinez-Escala, Ari B Gelman, et al.
Pageof 19